13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 47 holding rows worth $1,095,100,823.
- Accession
- 0001213900-26-089935
- Filer
- CIK 1674712
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 47 entries on the cover page, a total value of $1,095,100,823 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,095,100,823 with VALUE read as dollars as filed, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 5,094,668 | $95,015,558 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 271,116 | $90,766,926 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 4,127,412 | $75,614,188 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,682,097 | $58,436,050 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 414,899 | $55,289,441 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,379,769 | $43,131,579 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,805,816 | $41,918,891 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 557,172 | $39,113,474 | dollars as filed | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,903,000 | $38,192,410 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 2,500,000 | $36,375,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 6,694,637 | $35,414,630 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,557,466 | $34,591,320 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 353,998 | $34,507,725 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 1,208,858 | $31,901,763 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,844,758 | $30,254,031 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 7,299,909 | $28,469,645 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,400,000 | $27,258,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 800,000 | $25,964,000 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 4,322,747 | $23,991,246 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,612,903 | $23,338,706 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,848,786 | $20,022,352 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 4,246,568 | $18,557,502 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 722,020 | $18,050,500 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 2,751,032 | $17,964,239 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 7,757,060 | $16,987,961 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 3,153,640 | $15,263,618 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 3,555,250 | $11,519,010 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,671,797 | $11,099,900 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 575,000 | $10,758,250 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 1,350,000 | $8,923,500 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,927,710 | $8,790,358 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 671,843 | $8,404,756 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 90,500 | $8,379,395 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 1,166,667 | $8,283,336 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 260,000 | $6,747,000 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,184,713 | $6,592,356 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 813,666 | $6,326,253 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 275,000 | $5,082,000 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 2,325,000 | $4,185,000 | dollars as filed | |
| Valneva SE ADR | 92025Y103 | COM | 763,199 | $3,991,531 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,650,440 | $3,003,801 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 550,000 | $2,579,500 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 292,743 | $2,251,194 | dollars as filed | |
| INMED PHARMACEUTICALS INC | 457637700 | COM NEW | 798,377 | $1,237,484 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 72,414 | $278,794 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 465,471 | $239,904 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 4,675 | $36,746 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-26-089935 | this filing | 2026-08-14 | acceptance time not in the bulk data set |